Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants
Qian Wang(Army Medical University), Nanshan Zhong(State Key Laboratory of Respiratory Disease), Pingchao Li(Chinese Academy of Sciences), Suhua Guan(Guangzhou Experimental Station), Hengchun Li(Chinese Academy of Sciences), Liqiang Feng(Chinese Academy of Sciences), Chunhua Wang(Tokushima University), Xiaolin Liu(The Fifth People’s Hospital of Suzhou), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Bo Liu(Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Zhengyuan Zhang(Ruijin Hospital), Jing Sun(First Affiliated Hospital of Guangzhou Medical University), Zijian Liu(Chinese Academy of Sciences), Si Chen(Institut Pasteur), Li Yin(Chinese Academy of Sciences), Ying Feng(First Affiliated Hospital of Guangzhou Medical University), Linjing Shi(Chinese Academy of Sciences), Wei Wang(China Medical University), Xuefeng Niu(First Affiliated Hospital of Guangzhou Medical University), Linbing Qu(Guangzhou Institutes of Biomedicine and Health), Chenchen Yang(ZheJiang Academy of Agricultural Sciences), Jincun Zhao(ShanghaiTech University)
Cited by 31
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535